Guangzhou Zhiwei International Trade Co., Ltd. – Trademark Portfolio
Entity Type: 99
Guangzhou Zhiwei International Trade Co., Ltd. holds 1 U.S. trademark filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 9 (Computers & Electronics) — 1 filings in this category. Currently, 1 trademark is registered. Notable registered marks include VEXZEPY. The owner is based in Guangzhou, Guangdong.
Room F342-343, 3rd Floor, Xingnanhui Creative Park, No. 2 Yuangangzhong Road, Nancun Town, Panyu District
Guangzhou, Guangdong 511400 , CN
Showing of trademarks Trademarks
Trademark Classifications
Guangzhou Zhiwei International Trade Co., Ltd.'s trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Frequently Asked Questions
How many trademarks does Guangzhou Zhiwei International Trade Co., Ltd. have?
Guangzhou Zhiwei International Trade Co., Ltd. has 1 U.S. trademark filed with the USPTO. Of these, 1 registered.
What trademark classes does Guangzhou Zhiwei International Trade Co., Ltd. file in?
Guangzhou Zhiwei International Trade Co., Ltd. files trademarks across 1 Nice Classification class. The most active classes are Class 9 (Computers & Electronics). Class 9 covers scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments.
What are Guangzhou Zhiwei International Trade Co., Ltd.'s most well-known trademarks?
Guangzhou Zhiwei International Trade Co., Ltd.'s registered trademark portfolio includes well-known marks such as VEXZEPY. These are among 1 currently registered trademark in the portfolio.
What is Guangzhou Zhiwei International Trade Co., Ltd.'s trademark registration success rate?
Guangzhou Zhiwei International Trade Co., Ltd. has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.